Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction : Observations from the TIMI 14 trial

In the presence of ST-elevation myocardial infarction, patients with successful epicardial reperfusion (TIMI 3 flow) but persistent ST elevation on a 12-lead ECG are at high risk for subsequent death and left ventricular dysfunction. In the TIMI 14 trial, a dose-ranging angiographic study, combined...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2000-01, Vol.101 (3), p.239-243
Hauptverfasser:	DE LEMOS, J. A, ANTMAN, E. M, VAN DER WIEKEN, R, DE WERF, F. V, BRAUNWALD, E, GIBSON, C. M, MCCABE, C. H, GIUGLIANO, R. P, MURPHY, S. A, COULTER, S. A, ANDERSON, K, SCHERER, J, FREY, M. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Abciximab Antibodies, Monoclonal - administration & dosage Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Coronary Circulation - drug effects Drug Therapy, Combination Electrocardiography Female Humans Immunoglobulin Fab Fragments - administration & dosage Male Medical sciences Middle Aged Myocardial Infarction - drug therapy Myocardial Infarction - physiopathology Myocardial Reperfusion Pharmacology. Drug treatments Tissue Plasminogen Activator - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!